Drug firm Granules India on Thursday announced divestment of its entire stake in its joint venture firm Granules OmniChem to its JV partner for an undisclosed sum.
Granules OmniChem is an equal joint venture between Granules lndia and SA Ajinomoto Omnichem NV.
"The proposed divestment of our 50 per cent stake in the joint venture aligns with our focus on strengthening our core area of business. With this transaction, SA Ajinomoto Omnichem NV will take over full control of the contract research and manufacturing services (CRAMS) business," Granules India said in a regulatory filing.
"Through this deal, we would like to extend our support to our joint venture partner for their business plan to integrate their small and large molecule businesses which in turn strengthens their business operation and client relations," Granules India Chairman and Managing Director Krishna Prasad Chigurupati said.
The manufacturing facility of this joint venture is located in Visakhapatnam.
Conclusion of this transaction is subject to fulfilment of certain closing conditions as well as customary government approvals, the company added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app